Subtractive proteomics to identify targets for vaccine development against vancomycin-resistant Enterococcus faecalis

Area of Science:

• Microbiology
• Immunology
• Drug Discovery

Background:

• Enterococci species are a growing cause of infections.
• Vancomycin resistance in Enterococci (VRE) necessitates novel therapeutic strategies.
• Effective treatments against VRE are crucial due to increasing resistance.

Purpose of the Study:

• To identify potential drug and vaccine targets against VRE.
• To predict B cell and T cell epitopes for vaccine development.
• To address the challenge of vancomycin resistance in Enterococcus faecalis.

Main Methods:

• Subtractive proteomics was used to identify unique protein targets.
• Reverse vaccinology approaches were employed for epitope prediction.
• Analysis focused on the VRE V583 strain.

Main Results:

• 73 unique non-homologous protein sequences were identified from 805 total.
• These proteins serve as potential targets for novel drug and vaccine development.
• Specific targets were identified for countering VRE infections.

Conclusions:

• Novel targets in VRE V583 have been identified.
• This research aids in designing effective vaccines against VRE.
• Protease EEP proteins are highlighted as potential vaccine targets.